Sagent Pharmaceuticals Reports Second Quarter 2014 Financial Results
GlobeNewswire - Wed Jul 30, 6:01AM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2014.
UPDATE: Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2014 Financial Results
GlobeNewswire - Thu Jul 17, 5:12PM CDT
In a release issued earlier today by Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), the time of the teleconference and webcast was 9 a.m. ET. The updated time of the teleconference and webcast is now 10 a.m. ET. The full, updated release follows:
Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2014 Financial Results
GlobeNewswire - Thu Jul 17, 3:15PM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the 2014 second quarter pre-market on Wednesday, July 30, 2014 and will host a teleconference and webcast at 9 a.m. ET to review the results.
Can the Rally in Sagent Pharmaceuticals (SGNT) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 7:40AM CDT
Can the Rally in Sagent Pharmaceuticals (SGNT) Shares Continue?
Moving Average Crossover Alert: Sagent (SGNT) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 8:17AM CDT
Moving Average Crossover Alert: Sagent (SGNT)
Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta
PR Newswire - Mon Jun 30, 6:50AM CDT
Today, Analysts Review released its analysts' notes regarding Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Puma Biotechnology, Inc. (NYSE: PBYI), Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4240-100free.
Affiliated Managers Group Set to Join S&P 500; LaSalle Hotel Properties, Rayonier Advanced Materials, TimkenSteel, Belden to Join the S&P MidCap 400; Others to Join S&P SmallCap 600
PR Newswire - Tue Jun 24, 5:50PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
Sagent Pharmaceuticals Named to Crain's Chicago Business 2014 Fast Fifty List
GlobeNewswire - Mon Jun 09, 7:09AM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leading specialty pharmaceutical company with an emphasis on the injectable market, has been ranked seventh on Crain's 2014 Fast Fifty list, published by Crain's Chicago Business. This marks the second consecutive year that Sagent has been selected as one of the leading growth companies in Chicago, topping the charts as number one in 2013. The Crain's Fast Fifty is an annual ranking that features the fastest-growing companies in Chicago.
Sagent Pharmaceuticals reports market availibility of Adenosine Injection, USP
M2 - Tue Apr 01, 6:37AM CDT
Pharmaceutical company Sagent Pharmaceuticals Inc (NasdaqGS:SGNT) stated on Monday that it has introduced Adenosine Injection, USP, in two preservative- free vial presentations.
Sagent Pharmaceuticals and the Chicago Innovation Awards to Ring NASDAQ
GlobeNewswire - Mon Mar 31, 7:12AM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation, in New York City on Monday, March 31, to close the NASDAQ Stock Market, the premier exchange for technology companies. The event, arranged by the Chicago Innovation Awards, will emphasize the surge of innovation that is occurring in the Chicago region and shine a spotlight on the organizations that make up its vibrant economy.
Sagent Pharmaceuticals Announces the Launch of Adenosine Injection, USP
GlobeNewswire - Mon Mar 31, 7:12AM CDT
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Adenosine Injection, USP, a pharmacologic stress agent, in two preservative- free vial presentations. According to IMS, for the 12 months ending January 2014, the US market for Adenosine Injection, USP approximated $43 million. As with all products in Sagent's portfolio, Adenosine features the company's PreventIV Measures packaging and labeling, designed to help reduce medication errors.
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Two Lots of Zoledronic Acid Injection, 5mg/100mL due to Potential Lack of Container Integrity
GlobeNewswire - Tue Mar 04, 11:04AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the voluntary nationwide recall of two lots of Zoledronic Acid Injection, 5mg/100mL premix bag (NDC number 25021-830-82) distributed by Sagent. Sagent has initiated this voluntary recall of Zoledronic Acid Injection, 5mg/100mL to the user level due to the discovery of four (4) leaking premix bags detected during an investigation conducted in response to a product complaint. The subject bags were not administered to patients as the leakage was readily apparent.
Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Tue Feb 11, 6:00AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced financial results for the fourth quarter and fiscal year ended December 31, 2013.
Pentagon Awards $1.23 Billion in Defense Contracts Tuesday
Rich Smith, The Motley Fool - Motley Fool - Tue Feb 04, 5:30PM CST
The Department of Defense awarded only seven defense contracts Tuesday, yet still managed to hand out $1.23 billion worth of work. More than half the funds awarded went to a single recipient, privately held government contractor KS International...
Sagent Pharmaceuticals opens National Research Centre in Chengdu, China
M2 - Tue Feb 04, 6:10AM CST
US-based specialist pharmaceutical company Sagent Pharmaceuticals Inc (NasdaqGS:SGNT) reported on Monday the opening of its National Research Centre (NRC) in China.
Sagent Pharmaceuticals Launches National Research Center in Chengdu, China
GlobeNewswire - Mon Feb 03, 7:00AM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced the launch of its National Research Center ("NRC"
Sagent Pharmaceuticals Sets Date and Time for Release of Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Thu Jan 30, 3:30PM CST
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will release financial results for the 2013 fourth quarter and fiscal year end pre-market on Tuesday, February 11, 2014 and will host a teleconference and webcast at 9 a.m. ET to review the results.
Regulus (RGLS) Jumps: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 17, 8:46AM CST
Regulus was a big mover last session, with shares rising nearly 6%.
Sucampo (SCMP) Worth Watching: Stock Rises 11.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 8:25AM CST
Sucampo Pharmaceuticals was a big mover last session, with shares rising nearly 12%.
IGI, Laboratories (IG) Soars: Stock Adds 10.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 7:57AM CST
IGI, Laboratories, Inc. (IG) was a big mover last session, as the company saw its shares rise over 10% on the day.